Trial NCT02902809

View at ClinicalTrials.gov 
Org. Study IDs: D2210C00029

Last trial update was posted on 2019-09-06

MeSH Interventions

Antibodies, Monoclonal

MeSH Conditions

Asthma

Other Conditions

Inadequately Controlled Asthma

Stopping Reasons

The study was terminated due to the discontinuation of the tralokinumab asthma program (as per the results of the Phase III study [D2210C00008])

Limitations And Caveats

Study was terminated due to discontinuation of tralokinumab asthma program. Study was reported in a synopsis format. Individual listings of laboratory variables, physical examinations, vitals and ECG were evaluated for safety signal.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID